News

DGTHG Basic Research Highlights 2018

February 21, 2018

Johannes Holfeld and Can Tepeköylü represented the CARE Lab at the 47th Annual Meeting of the German Society for Cardiothoracic Surgery (DGTHG) in Leipzig, Germany. Their abstracts „miR-19a-3p containing exosomes improve cardiac function in ischemic myocardium“ and „Toll-like receptor 3 mediates the onset of calcific aortic valve disease“ were awarded as basic research highlights and presented at the closing ceremony.


Young Investigator Award – Austrian Society for Radiation Protection in Medicine 2017

November 19, 2017

In November 2017, Can Tepeköylü received the “Young Investigator Award“ of the “Austrian Society for Radiation Protection in Medicine“ at the society’s annual meeting in Vienna.  He presented his work upon a crucial pathomechanism the development of radiation induced calcific aortic valve disease. Briefly, radiation leads to the release of danger associated molecular patterns and a concomitant activation of the innate immune system. The work is of great significance, as it reveals a promising pharmacolgical target for the prevention of radiation-associated valve disease.


ESOT Research Highlight and Young Investigator Award Austrotransplant 2017

November 10, 2017

A joint project with  the Department of Transplantation Surgery Innsbruck (Dr. Thomas Resch) received a national and an international award. The project titled “TLR3 – A novel target for the prevention of ischemia-reperfusion injury in cardiac transplantation“ received the “Young Investigator’s Award“ at the Austrotransplant Meeting 2017 in Zell am See, Austria. At the same time it was chosen as “Research Highlight“ at the highly reknown biannual international congress of the “European Society for Organ Transplantation 2017“ (ESOT)  in Barcelona, Spain. In this project, we could highlight a crucial mechanism of ischemia-reperfusion injury in heart transplantation. At the same time, we could reveal a novel target for the attenuation of ischemia reperfusion injury, thereby improving organ quality.

 


ESC Research Highlights 2017

October 1, 2017
The “CARE Lab“ actively participated at the ESC congress in Barcelona with 2 oral presentations. Johannes Holfeld presented his latest work on exosome release upon shock wave therapy, while Can Tepeköylü reported our results concerning the pathophysiology of aortic valve calcification. The study was awarded as „Basic Science Research Highlight 2017“ during the closing ceremony and was chosen amongst more than 10.000 abstracts . Our work describes a crucial mechanism of calcification and the discovery of a knock-out strain which does not develop the phenotype of calcific aortic valve disease.

European SCAD study group

October 1, 2017

Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of non-atherosclerotic acute coronary syndromes, predominantly afflicting young women without conventional atherosclerotic risk factors. Like all rarer diseases however, a better understanding of SCAD will require international collaboration. The CARE Lab therefore joined the European SCAD initiative of the European Society of Cardiology (ESC) and aims to participate in a European SCAD registry as well as to promote knowledge on the cardiosurgical aspects of this disease. Johannes Holfeld serves as an Executive Committee Member of the ESC EORP SCAD registry.

At this year’s ESC congress in Barcelona we furthermore initiated a collaboration that will together with geneticists work on the elucidation of the underlying pathomechanism of SCAD. Gene candidates identified from the SCAD registry will be further investigated with the experimental expertise of the CARE Lab.

 


20th ISMST Congress

June 27, 2017

During the 20th Congress of the International Society of Medical Shockwave Treatment (ISMST) in San Sebastian, Spain, CARE Lab members held several oral presentations and were awarded twice.  Leo Pölzl and Michael Graber were awarded  as “Best Original Works on ESWT Basic Research”  and Can Tepeköylü was awarded as “Best Presentation”.

 


Annual Meeting of the Austrian Society for Cardiology and Cardiac Surgery / Best Abstract Award and Hans-Heinz Khünl-Brady Innovation Award 2017

June 9, 2017

The Annual Meeting of the Austrian Society for Cardiology and Cardiothoracic Surgery took place in Salzburg from the 7th-10th of June. CARE Lab participated actively and received the Best Abstract Award (Can Tepeköylü) and the Best Presentation Award (Michael Graber). Johannes Holfeld was honored with the „Hans-Heinz Khünl-Brady Innovation Award“ of the Austrian Society of Cardiothoracic Surgery for his work on Cardiac Shockwave Therapy.


DIGEST award 2017

April 30, 2017

In April 2017 Priv.Doz. Dr. Johannes Holfeld was awarded the DIGEST – Deutschsprachige Internationale Gesellschaft für Extrakorporale Stoßwellentherapie – prize 2017 for his publication of the mechanisms of Toll-like receptor 3 in shock wave therapy.

Title of the publication:

Holfeld J, Tepeköylü C, Reissig C, Lobenwein D, Scheller B, Kirchmair E, Kozaryn R, Albrecht-Schgoer K, Krapf C, Zins K, Urbschat A, Zacharowski K, Grimm M, Kirchmair R, Paulus P.
Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle.
Cardiovasc Res. 2016 Feb 1;109(2):331-43. doi: 10.1093/cvr/cvv272.

 

 


Young Investigator Award – Cardiology Congress Innsbruck 2017

March 4, 2017

In March 2017 Leo Pölzl was awarded the Young Investigator Award of the Cardiology Congress Innsbruck 2017 for his work on Exosomes.

Title of his presentation:
miR-19a-3p containing exosomes improve cardiac function in ischemic myocardium
Pölzl L, Graber M, Hirsch J, Lobenwein D, Zipperle J, Blumer M, Kirchmair E, Kirchmair R, Paulus P, Davidson S, Grimm M, Holfeld J, Tepeköylü C.

 


Best Basic Research Poster: Integrated Management of Acute and Chronic Cardiovascular Disease

February 1, 2017

In January 2017 Dr. Michael Graber was awarded the Best Basic Research Poster of the Integrated Management of Acute and Chronic Cardiovascular Disease Congress in Innsbruck for our work on the calcific aortic valve disease.

Title of his poster:

Inhibition of Toll-Like receptor 3 prevents from calcific aortic valve disease.
Graber M, Pölzl L, Hirsch J, Kirchmair E, Degenhart G, Lobenwein D, Fuchs C, Grimm M, Holfeld J, Tepeköylü C.